CRYSTALGENOMICS INVITES CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,130 KRW | +0.97% |
|
-0.32% | +12.79% |
| Sales 2022 | 38.64B 28.09M 2.25B | Sales 2023 | 4.88B 3.55M 284M | Capitalization | 208B 151M 12.12B |
|---|---|---|---|---|---|
| Net income 2022 | -23.87B -17.35M -1.39B | Net income 2023 | -48.92B -35.57M -2.85B | EV / Sales 2022 | 5.93 x |
| Net cash position 2022 | 11.83B 8.6M 689M | Net cash position 2023 | 12.29B 8.93M 715M | EV / Sales 2023 | 40.2 x |
| P/E ratio 2022 |
-10.1
x | P/E ratio 2023 |
-4.2
x | Employees | 68 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.97% | ||
| 1 week | -0.32% | ||
| Current month | -16.53% | ||
| 1 month | -18.28% | ||
| 3 months | +21.55% | ||
| 6 months | +18.34% | ||
| Current year | +12.79% |
1 week
3 040.00
3 295.00
1 month
3 040.003 880.00
Current year
2 505.004 385.00
1 year
2 455.005 950.00
3 years
2 455.009 070.00
5 years
2 455.0014 766.67
10 years
2 455.0019 794.87
| Managers | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Young-Joon Yoo
AUD | Comptroller/Controller/Auditor | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Jin-Woo Lee
BRD | Director/Board Member | 59 | 30/03/17 |
Kyung-Sook Cho
BRD | Director/Board Member | 64 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 3,130 | +0.97% | 108,961 |
| 25/04/24 | 3,100 | +0.65% | 69,045 |
| 24/04/24 | 3,080 | -1.60% | 73,124 |
| 23/04/24 | 3,130 | -2.03% | 70,517 |
| 22/04/24 | 3,195 | +1.75% | 108,095 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
Sector
Pharmaceuticals
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +12.79% | 174M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- A083790 Stock
